Quotient Sciences Acquires Arcinova

Read the press release here

Webinars from the Arcinova team

May 31, 2021

Assessment of fluoride exposure by GCMS: Successes and lessons learnt

About this Event A client sought approval for a volatile pain killing compound to be used in emergency situations
January 19, 2021

The Race to Clinic: Removing Compound Supply Obstacles from the Critical Path

Webinar Overview With the price of bringing a drug to market estimated at $2.5 billion,1 avoidable cost increases caused by delays is a failing few companies are willing t
October 13, 2020

ADME/Human AME Virtual Symposium - Recent insights on optimizing your ADME/hAME study

About this Event In this recorded webinar you can join experts from
August 5, 2020

The Need for Speed: gaining the right support to accelerate your small molecule candidate

About this Event This digital event was hosted by Arcinova and featu
July 6, 2020

Preformulation to FIH: avoiding pitfalls for early clinical success

About this Event Preformulation characterization of new chemical ent
June 1, 2020

Latest hybrid LC-MS techniques to resolve your peptide analytical questions.

Michael Blackburn, Bioanalytical Scientist (Method Development), Bioanalytical Servicest, here at Arcinova, discusses using MSIA with mass spectrometry to analyse therapeutic pe
March 12, 2020

API Development Using Flow Chemistry & Synthetic Biology

Find our more about API Development using Flow Chemistry & Synthetic Biology with Paul Quigley, Head of Drug Substance and Isotope Labelling. 
June 12, 2019

New Perspectives in Flow Chemistry

Pharmaceutical companies are currently investing in the development of continuous chemical processes to reduce costs and accelerate the delivery of new molecules to the market. While the spotlight